Cargando…
Severe progression of idiopathic pulmonary fibrosis post-COVID-19 infection
A 79-year-old woman presented with a week-long history of shortness of breath. She had a background of idiopathic pulmonary fibrosis (IPF) which was stable and had not required any antifibrotic treatment. A month prior to this presentation, she was admitted with COVID-19 pneumonia, with maximal oxyg...
Autores principales: | Earl, Naomi, Schoeneberg, Dillon, Davidson, Philip D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527160/ https://www.ncbi.nlm.nih.gov/pubmed/34667037 http://dx.doi.org/10.1136/bcr-2021-244472 |
Ejemplares similares
-
Dyspnoea with progressive “idiopathic” pulmonary fibrosis
por: Puri, Chahat, et al.
Publicado: (2021) -
Clinicopathological Outlines of Post-COVID-19 Pulmonary Fibrosis Compared with Idiopathic Pulmonary Fibrosis
por: Cîrjaliu, Roxana-Elena, et al.
Publicado: (2023) -
Bosentan for pulmonary hypertension secondary to idiopathic pulmonary fibrosis
por: Onda, Naomi, et al.
Publicado: (2014) -
Idiopathic Pulmonary Fibrosis and Post-COVID-19 Lung Fibrosis: Links and Risks
por: Patrucco, Filippo, et al.
Publicado: (2023) -
Successful Lung Transplantation for Severe Post-COVID-19 Pulmonary Fibrosis
por: Hall, David J., et al.
Publicado: (2022)